Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 23073328)

1.

Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies.

Fujita H, Lennerz JK, Chung DC, Patel D, Deshpande V, Yoon SS, Lauwers GY.

Am J Surg Pathol. 2012 Nov;36(11):1709-17. doi: 10.1097/PAS.0b013e31826ca204.

PMID:
23073328
2.

Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.

Barber ME, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick RH, Caldas C, Fitzgerald RC.

J Pathol. 2008 Nov;216(3):286-94. doi: 10.1002/path.2415.

PMID:
18825658
3.

Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?

Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P, Parry S, Charlton A, Martin I.

Gut. 2005 Apr;54(4):461-8.

4.

Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.

Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, Kingham K, Chun N, Ford JM, Longacre TA.

Am J Surg Pathol. 2008 Jun;32(6):799-809. doi: 10.1097/PAS.0b013e31815e7f1a.

PMID:
18391748
5.

CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.

Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM.

Ann Surg. 2007 Jun;245(6):873-9.

6.

[Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene].

Svrcek M.

Ann Pathol. 2011 Oct;31(5):381-4. doi: 10.1016/j.annpat.2011.07.007. Epub 2011 Sep 28. Review. French. No abstract available.

PMID:
21982246
7.

Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.

Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simões M.

J Pathol. 2004 Jun;203(2):681-7.

PMID:
15141383
8.

Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance.

Lim YC, di Pietro M, O'Donovan M, Richardson S, Debiram I, Dwerryhouse S, Hardwick RH, Tischkowitz M, Caldas C, Ragunath K, Fitzgerald RC.

Gastrointest Endosc. 2014 Jul;80(1):78-87. doi: 10.1016/j.gie.2013.11.040. Epub 2014 Jan 25.

PMID:
24472763
9.

Hereditary gastric cancer.

Oliveira C, Seruca R, Carneiro F.

Best Pract Res Clin Gastroenterol. 2009;23(2):147-57. doi: 10.1016/j.bpg.2009.02.003. Review.

PMID:
19414142
10.

CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling.

Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ, Figueiredo J, van Riel E, Sijmons RH, Plukker JT, van Hillegersberg R, Dekker E, Oliveira C, Cats A, Hoogerbrugge N; Dutch Working Group on Hereditary Gastric Cancer.

Int J Cancer. 2012 Jul 15;131(2):367-76. doi: 10.1002/ijc.26398. Epub 2011 Oct 23.

PMID:
22020549
11.

Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.

Cisco RM, Norton JA.

Future Oncol. 2008 Aug;4(4):553-9. doi: 10.2217/14796694.4.4.553. Review.

PMID:
18684065
12.

Hereditary gastric cancer.

Carneiro F.

Pathologe. 2012 Nov;33 Suppl 2:231-4. doi: 10.1007/s00292-012-1677-6. Review.

PMID:
23052347
13.

Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers.

Lee AF, Rees H, Owen DA, Huntsman DG.

Am J Surg Pathol. 2010 Jul;34(7):1007-13. doi: 10.1097/PAS.0b013e3181e28985.

PMID:
20534996
14.

Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.

Hebbard PC, Macmillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, Kwan A, Boone D, Bursey F, Green J, Fernandez B, Fontaine D, Wirtzfeld DA.

Ann Surg Oncol. 2009 Jul;16(7):1890-5. doi: 10.1245/s10434-009-0471-z. Epub 2009 May 1.

PMID:
19408054
15.

Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.

Francis WP, Rodrigues DM, Perez NE, Lonardo F, Weaver D, Webber JD.

JSLS. 2007 Jan-Mar;11(1):142-7.

16.

Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?

Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH.

Cancer. 2001 Jul 1;92(1):181-7. Review.

PMID:
11443625
17.

Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.

Bardram L, Hansen TV, Gerdes AM, Timshel S, Friis-Hansen L, Federspiel B.

Fam Cancer. 2014 Jun;13(2):231-42. doi: 10.1007/s10689-013-9698-8.

PMID:
24389957
18.

Hereditary diffuse gastric cancer: diagnosis and management.

Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, Harawira P, McLeod M, Parry S, Charlton A, Findlay M, Cox B, Humar B, More H, Guilford P.

Clin Gastroenterol Hepatol. 2006 Mar;4(3):262-75. Review.

PMID:
16527687
19.
20.

Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.

Newman EA, Mulholland MW.

J Am Coll Surg. 2006 Apr;202(4):612-7.

PMID:
16571431
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk